Pharmacologic effects of calcium channel blockers on restenosis

Journal of Cardiovascular Pharmacology

Volumn 33, Issue SUPPL. 2, 1999, Pages

  Thaulow, Erik ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Amlodipine; Angioplasty; Calcium channel blockers; Ischemia; Restenosis

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT;

CORONARY ARTERY DILATATION; CORONARY ARTERY SPASM; CORONARY STENT; DRUG EFFICACY; DRUG MECHANISM; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; MITOSIS INHIBITION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENT DISEASE; RESTENOSIS; REVIEW; THROMBOCYTE AGGREGATION INHIBITION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CALCIUM CHANNEL BLOCKERS; CORONARY DISEASE; HUMANS; RECURRENCE; STENTS;

EID: 0032973218     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199900002-00004     Document Type: Review

References (48)

1. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331: 489-95.
2. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
3. Hermans WRM, Rensing BJ, Strauss BH, Serruys PW. Prevention of restenosis after percutaneous transluminal coronary angioplasty (PTCA): the search for a magic bullet. Am Heart J 1991;122:171-87.
4. 2 receptor blockade: a randomized, double blind, placebo-controlled trial. Circulation 1991;84:1568-80.
5. Hillegass WB, Ohman M, Leimberger JD, Califf RM. A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty. Am J Cardiol 1994;73: 835-9.
6. Rensing BJ, Hermans WRM, Beatt KJ, et al. Quantitative angiographic assessment of elastic recoil after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1990;66:1039-44.
7. Rensing BJ, Hermans WR, Strauss BH, Serruys PW. Regional differences in elastic recoil after percutaneous transluminal coronary angioplasty: a quantitative angiographic study. J Am Coll Cardiol 1991;17:34B-8B.
8. Hanet C, Wijns W, Michel X, Schroeder E. Influence of balloon size and stenosis morphology on immediate and delayed elastic recoil after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1991;18:506-11.
9. Steele PM, Chesebro JH, Stanson AW, et al. Balloon angioplasty: natural history of the pathophysiological response to injury in the pig model. Circ Res 1985;57:105-12.
10. Uchida Y, Hasegawa K, Kawamura K, Shibua I. Angioscopic observation of the coronary luminal changes induced by coronary angioplasty. Am Heart J 1989;117:769-76.
11. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest 1983;49:208-15.
12. Essed CE, van den Brand M, Decker AE. Transluminal coronary angioplasty and early restenosis: fibrocellular occlusion after wall laceration. Br Heart J 1983;49:393-6.
13. Austein GE, Ratliff MB, Hollman J, Tabei S, Philips DF. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary after stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985;6:369-75.
14. Thaulow E, Føysaher T, Dale J, Vatne K. Failure of combined acetylsalicylic acid and dipyridamole to prevent occlusion of aortocoronary bypass grafts. Scand J Thorac Cardovasc Surg 1987;21:215-20.
15. Chesebro JF, Fuster V, Elveback LR, et al. Effect of dipyridamole and aspirin on late vein-graft potency after aortocoronary bypass operations. N Engl J Med 1989;310:209-14.
16. Frida XE, Gelman JS, Feldman RL, Hill JA, Pepine CJ, Scott E. Comparison of diltiazem and nifedipine alone and in combination in patients with coronary artery spasm. J Am Coll Cardiol 1987;9:412-9.
17. Chahine RA, Feldman RL, Giles TD, et al. Randomized placebo-controlled trial of amlodipine in vasospastic angina. J Am Coll Cardiol 1993;21:1365-70.
18. Kiyomoto A, Sasaki Y, Odawara A, Morita T. Inhibition of platelet aggregation by diltiazem. Comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites. Circ Res 1983;52(SupplI):115-9.
19. Ikeda Y, Kikuchi M, Toyama K, Watanabe K, Ando Y. Inhibition of human platelet functions by verapamil. Thromb Haemost 1981;45:158-61.
20. Hernandez R, Carvajal AR, Armas-de-Hernandez MJ, et al. The effects of the calcium antagonist amlodipine on blood pressure and platelet aggregation in hypertensive patients. Postgrad Med J 1991;67(Supp15):S38-40.
21. Yang Z, Noll G, Luscher TF. Calcium antagonists differently inhibit proliferation of human coronary smooth muscle cells in response to pulsatile stretch and platelet derived growth factor. Circulation 1993;88:832-6.
22. McMurray HF, Chahwala SB. Amlodipine exerts a potent antimigrational effect on aortic smooth muscle cells in culture. J Cardiovasc Pharmacol 1992;20(Suppl A):S54-6.
23. Parmley WW, Blumlein S, Sievers R. Modification of experimental atherosclerosis by calcium-channel blockers. Am J Cardiol 1985;55:165B-71B.
24. ++ antagonist lanthanum: possible role of calcium in atherogenesis. J Clin Invest 1980;65:967-81.
25. Waters D, Lesperance J. Interventions that beneficially influence the evolution of coronary atherosclerosis. The case for calcium channel blockers. Circulation 1992;86(Suppl III):111-6.
26. Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Hecker H, Jost S, Deckers JW, on behalf of the Intact Group Investigators. Retardation of angiographic progression of coronary artery disease by nifedipine. Lancet 1990;335:1109-13.
27. Loaldi A, Polese A, Montorsi P, et al. Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowing in angina pectoris. Am J Cardiol 1989;64:433-9.
28. The Multicenter European Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Circulation 1992;86:100-10.
29. Parisi AR, Folland ED, Hartigan P, on behalf of the Veterans Affairs ACME Investigators. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326:10-6.
30. Deanfield JE, Detry J-MRG, Lichtlen PR, Magnani B, Sellier P, Thaulow E, for the CAPE Study Group. Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-Ischemia Program in Europe (CAPE-trial). J Am Coll Cardiol 1994;24:1460-7.
31. Heyndrickx GR, Millard RW, McRitchie RJ, Maroko PR, Vatner SF. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 1975;56:978-85.
32. Ellis SG, Henschke CI, Sandor T, Winne J, Braunwald W, Kloner RA. Time course of functional and biochemical recovery of myocardium salvaged by reperfusion. J Am Coll Cardiol 1983;1: 1047-55.
33. Kloner LA, Ellis SG, Lange R, Braunwald E. Studies of experimental coronary artery reperfusion: effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage. Circulation 1983;68(Suppl I):I8-15.
34. Opie LH. Postischemic stunning. The case for calcium as the ultimate culprit. Cardiovasc Drugs Ther 1991;5:895-900.
35. Fitzpatrick DB, Karmazyn M. Comparative effects of calcium channel blocking agents and varying extracellular calcium concentration on hypoxia/reoxygenation and ischemia/reperfusion-induced cardiac injury. J Pharmacol Exp Ther 1984;228:761-8.
36. Higgins AJ, Blackburn KJ. Prevention of reperfusion damage in working rat hearts by calcium antagonist and calmodulin antagonist. J Mol Cell Cardiol 1984;16:127-8.
37. Nayler WG, Panagiotopoulos S, Elz JS, Daly MJ. Calcium-mediated damage during post-ischemia reperfusion. J Mol Cell Cardiol 1988;20(Suppl II):41-54.
38. Sheiban I, Tonni S, Benussi P, Marini A, Trevi GP. Left ventricular dysfunction following transient ischemia induced by transluminal coronary angioplasty. Beneficial effects of calcium antagonists against post-ischemic myocardial stunning. Eur Heart J 1993;14(Suppl A):14-21.
39. Amende I, Hermann G, Simon G, Wenzlaff P, Lichtlen PR. Intracoronary nisoldipine: effects on acute myocardial ischemia during coronary angioplasty. Cardiovasc Drugs Ther 1989;2: 807-13.
40. Bonnier JJRM, Huizer T, Troquay R, vau Es Gerrit E, de Jong JW. Myocardial protection by intravenous diltiazem during angioplasty of single-vessel coronary artery disease. J Am Cardiol 1990;66: 145-50.
41. Gross GJ, Farber ME, Pieper GM. Effects of amlodipine on myocardial ischemia-reperfusion injury in dogs. Am J Cardiol 1989;64:94I-100I.
42. Corcos T, David PR, Val PG, et al. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1985;109:926-31.
43. Whitworth HB, Roubin GS, Hollman J, et al. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1986;8:1271-6.
44. Hoberg E, Schwanz F, Schomig A, et al. Prevention of restenosis by verapamil in the Verapamil Angioplasty Study (VAS) [Abstract]. Circulation 1990;82(Suppl 3):III428.
45. O'Keefe JH, Giorge LV, Hartzler GO, et al. Effects of diltiazem on complications and restenosis after coronary angioplasty. Am J Cardiol 1991;67:373-6.
46. Unverdorben M, Kunkel B, Leucht M, Bachman K. Reduction of restenosis after PTCA by diltiazem? Circulation 1992;86:I53.
47. Serruys PW, Foley DP, Kirkeeide RL, King SB. Restenosis revisited: insights provided by quantitative coronary angiography. Am Heart J 1993;126:1243-67.
48. Davies RF, Habibi H, Klimke WP, et al. Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. J Am Coll Cardiol 1995;25:619-25.